Ctrv current stock price

Historical index on US Stock Market : C "Should I invest in ContraVir Pharmaceuticals stock?" "Should I trade "CTRV" stock today?" According to our live Forecast System, ContraVir Pharmaceuticals, Inc stock is a very good long-term (1-year) investment*. "CTRV" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis. CTRV - Contravir Pharmaceuticals News - Barchart.com Van Meerten Stock Picks. Jim Van Meerten's Daily Stock Picks highlights stocks you might want to consider for your portfolio, with Jim's editorials about current events and stock market commentary. Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar. Is ContraVir Pharmaceuticals Inc (CTRV) Undervalued? Dec 04, 2017 · This high level of volatility gives investors the opportunity to enter into the stock, and potentially buy at an artificially low price. A question to answer is whether CTRV’s current trading

Secureworks Corp Redemption of Losses, Sales are Up. Secureworks Corp announced earnings per share of $-0.06 and Sales of $141.33 millions in the fourth quarter, Company's decreased loss per share, versus $-0.15 eps, earned in the same quarter a year ago, although Secureworks Corp saw it's Sales rise by 8.63 % in the same period.

Van Meerten Stock Picks. Jim Van Meerten's Daily Stock Picks highlights stocks you might want to consider for your portfolio, with Jim's editorials about current events and stock market commentary. Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar. Is ContraVir Pharmaceuticals Inc (CTRV) Undervalued? Dec 04, 2017 · This high level of volatility gives investors the opportunity to enter into the stock, and potentially buy at an artificially low price. A question to answer is whether CTRV’s current trading Hepion Pharmaceuticals, Inc. (HEPA) Stock Analysis & News ... Get breaking news and analysis on Hepion Pharmaceuticals, Inc. (HEPA) stock, price quote and chart, trading and investing tools. Amended Current report (8-K/A) June 12, 2019. CTRV Stock News and Price / Contravir Pharmaceuticals Inc ... CTRV / Contravir Pharmaceuticals Inc CORRESP - - 07-18 sec.gov ContraVir Pharmaceuticals, Inc. 399 Thornall Street Edison, NJ 08837 June 5, 2019 VIA EDGAR United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Dorrie Yale Re: ContraVir Pharmaceuticals, Inc. Form S-1 File No. 333-231604 Dear Ms. Yale: Pursuant to Rule 461 of the …

May 04, 2019 · ContraVir Pharmaceuticals, Inc. (CTRV) is headed down in the market in today’s trading session. The stock, one that is focused on the biotechnology sector, is currently priced at $0.15 after falling -12.56% so far in today’s session.

Apr 26, 2017 · ContraVir Pharmaceuticals Inc (NASDAQ:CTRV) Edison, NJ-based ContraVir Pharmaceuticals Inc (NASDAQ:CTRV) shares plummeted on news that the Edison, NJ-based biotech firm would be pricing shares in their public offering at $1.00 per share.CTRV shares began their drop on April 20 and yesterday shares were worth half of their April 20 th highs. Volumes have been heavy – today … Current Report Filing (8-k) - Investors Hub CTRV Contravir Pharmaceuticals (MM) Current Report Filing (8-k) determined by dividing the $1,000 stated value per share of the Series E Preferred Stock by a conversion price of $6.00 per share. In addition, the conversion price per share is subject to adjustment for stock dividends, distributions, subdivisions, combinations or ContraVir Pharmaceuticals (CTRV) - Stock Market Stop May 28, 2019 · ContraVir Pharmaceuticals (CTRV) fell -14.81% with the finishing price of $0.11 in Friday Trading Session. The stock price showed -95.71% lower in value from one year high price and revealed 11.60% upward in value from its one year low price. News Releases - ContraVir Pharmaceuticals